These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Progress on study of treatment of age-related macular degeneration by pigment epithelial-derived factor].
    Author: Hou HY, Wang YS.
    Journal: Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):181-5. PubMed ID: 20388353.
    Abstract:
    Age-related macular degeneration (AMD) is a common cause of blindness in elderly population. Exploration of effective treatment of AMD has important significance. Pigment epithelial-derived factor (PEDF) is the most powerful endogenous inhibitor of angiogenesis. Increasing evidences, including results of phase I clinical trial, indicated that PEDF could significantly inhibit the development of choroidal neovascularization, which is the characteristic of wet AMD. Therefore, PEDF is one of the most potential therapeutic agents for AMD treatment.
    [Abstract] [Full Text] [Related] [New Search]